Persistent Asset Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$327K Hold
1,535
– – 0.09% 145
2026
Q2
$244K Buy
+1,535
New +$88.1K 0.07% 190
2025
Q4
– Sell
-412
Closed -$48.1K – 378
2025
Q3
$48.1K Buy
+412
New +$19.2K 0.03% 183

Other funds holding BMY

Persistent Asset Partners's BMY Position: Q3 2026 in Review

Persistent Asset Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 50 shares — an estimated $3.16K sold.

Persistent Asset Partners first reported a position in BMY in Q3 2025 and held it in 2 quarters. The position peaked at $1.34M in Q3 2025. 2,566 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Persistent Asset Partners reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 50 Bristol-Myers Squibb shares in Q3 2026, an estimated $3.16K.
  • Persistent Asset Partners first reported a position in Bristol-Myers Squibb in Q3 2025 and held it in 2 quarters.
  • Persistent Asset Partners's Bristol-Myers Squibb position peaked at $1.34M in Q3 2025.
  • 2,566 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.